• Home >
  • Advances in Oncolytic Immunotherapy

Advances in Oncolytic Immunotherapy

22-Dec-2017  /  Research Code: D758-00-66-00-00  /  SKU: HC02946-GL-TA_21325  /  
Region: Global

USD 250.00

* Required Fields

USD 250.00

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across oncolytic immunotherapy. Next generation oncoloytic viral therapies, reovirus platforms, and cancer management strategies are depicted. The corresponding clinical trials scenario is illustrated, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics techno

Table of Contents

Advances in Oncolytic ImmunotherapyInnovations in Oncolytic ImmunotherapyNext-generation Oncolytic Viral Company Announces Senior Leadership AppointmentLeveraging Coxsackievirus for Oncolytic ImmunotherapyNovel Reovirus Platform for Cancer ManagementPsiOxus Therapeutics to Receive Milestone Payment from Bristol-Myers Squibb Clinical Trial Analysis and Industry InteractionsClinical Pipeline for ViralyticsSummary of Key Contacts




Related Research

Analysis of Western European Molecular Imaging Market, Forecast to 2022

Release Date : 01-Aug-18

Region : Europe

Innovations in X-rays, Sonar, Ultrasound, Imaging Systems, and CT Scans

Release Date : 27-Jul-18

Region : Global

Innovations in Orthobiologics, Artifcial Intelligence in Medical Diagnosis, Non-invasive Health Monitoring, and Cybersecurity for Medical Devices

Release Date : 20-Jul-18

Region : Global

Reimagining Healthcare Delivery: Impact of Gamification and Patient Engagement

Release Date : 29-Jun-18

Region : North America

Innovations in Pain Management: A Technology Blueprint to Counter Opiod Addiction

Release Date : 29-Jun-18

Region : Global

Organ-on-a-chip Innovations Fueling Drug Screening Applications

Release Date : 29-Jun-18

Region : Global

Innovations in Diabetes Cure, Safer CAR-T Therapy, and Pediatric Genetic Disease Treatment

Release Date : 29-Jun-18

Region : Global

Vision 2025—Healthcare in the Smart Home

Release Date : 27-Jun-18

Region : Global

Innovations in Retinal Scanning, Neural Imaging, Post-operative Imaging, MRI Diagnostics, Breast Cancer Imaging, and Drug Efficacy Assessing Tools

Release Date : 22-Jun-18

Region : Global

Advancements in Pressure Sensors, Cancer Diagnosis, Implantable Devices, Drug Discovery, and Humidity Control

Release Date : 22-Jun-18

Region : Global

Advancements in Biomarker Assays and Stem Cell Therapies

Release Date : 22-Jun-18

Region : Global

Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022

Release Date : 21-Jun-18

Region : North America

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.